HomeCompareALR vs MRK

ALR vs MRK: Dividend Comparison 2026

ALR yields 151.52% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALR wins by $26.24M in total portfolio value
10 years
ALR
ALR
● Live price
151.52%
Share price
$1.32
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.29M
Annual income
$11,439,609.73
Full ALR calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ALR vs MRK

📍 ALR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALRMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALR + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALR pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALR
Annual income on $10K today (after 15% tax)
$12,878.79/yr
After 10yr DRIP, annual income (after tax)
$9,723,668.27/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ALR beats the other by $9,715,339.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALR + MRK for your $10,000?

ALR: 50%MRK: 50%
100% MRK50/50100% ALR
Portfolio after 10yr
$13.17M
Annual income
$5,724,703.93/yr
Blended yield
43.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ALR
No analyst data
Altman Z
0.5
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALR buys
0
MRK buys
0
No recent congressional trades found for ALR or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALRMRK
Forward yield151.52%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$26.29M$56.8K
Annual income after 10y$11,439,609.73$9,798.13
Total dividends collected$24.35M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ALR vs MRK ($10,000, DRIP)

YearALR PortfolioALR Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$25,852$15,151.52$11,206$366.19+$14.6KALR
2$64,268$36,606.51$12,650$502.35+$51.6KALR
3$153,818$85,051.27$14,407$694.19+$139.4KALR
4$354,829$190,243.94$16,585$967.82+$338.2KALR
5$789,814$410,147.27$19,342$1,363.89+$770.5KALR
6$1,698,323$853,222.02$22,913$1,947.19+$1.68MALR
7$3,531,849$1,714,643.01$27,662$2,823.89+$3.50MALR
8$7,111,590$3,332,511.93$34,159$4,173.35+$7.08MALR
9$13,880,629$6,271,227.52$43,337$6,308.80+$13.84MALR
10$26,291,883$11,439,609.73$56,776$9,798.13+$26.24MALR

ALR vs MRK: Complete Analysis 2026

ALRStock

AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and outpatient rehabilitation clinics and fitness services. As of December 31, 2021, it owned and operated or managed, 141 senior living communities located in 28 states with 20,105 living units, including 10,423 independent living apartments, 9,636 assisted living suites, which includes 1,872 of Bridge to Rediscovery memory care units, and one continuing CCRC, with 106 living units, including 46 SNF. The company was formerly known as Five Star Senior Living Inc. and changed its name to AlerisLife Inc. in January 2022. AlerisLife Inc. was incorporated in 2001 and is headquartered in Newton, Massachusetts.

Full ALR Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ALR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALR vs SCHDALR vs JEPIALR vs OALR vs KOALR vs MAINALR vs JNJALR vs ABBVALR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.